Abstract
Objective: The long-term consequences of traumatic brain injury (TBI) on brain structure remain uncertain. Given evidence that a single significant brain injury event increases the risk of dementia, brain-age estimation could provide a novel and efficient indexing of the long-term consequences of TBI. Brain-age procedures use predictive modeling to calculate brain-age scores for an individual using structural magnetic resonance imaging (MRI) data. Complicated mild, moderate, and severe TBI (cmsTBI) is associated with a higher predicted age difference (PAD), but the progression of PAD over time remains unclear. We sought to examine whether PAD increases as a function of time since injury (TSI) and if injury severity and sex interacted to influence this progression. Methods: Through the ENIGMA Adult Moderate and Severe (AMS)-TBI working group, we examine the largest TBI sample to date (n = 343), along with controls, for a total sample size of n = 540, to replicate and extend prior findings in the study of TBI brain age. Cross-sectional T1w-MRI data were aggregated across 7 cohorts, and brain age was established using a similar brain age algorithm to prior work in TBI. Results: Findings show that PAD widens with longer TSI, and there was evidence for differences between sexes in PAD, with men showing more advanced brain age. We did not find strong evidence supporting a link between PAD and cognitive performance. Interpretation: This work provides evidence that changes in brain structure after cmsTBI are dynamic, with an initial period of change, followed by relative stability in brain morphometry, eventually leading to further changes in the decades after a single cmsTBI. ANN NEUROL 2024;96:365–377.
Original language | English (US) |
---|---|
Pages (from-to) | 365-377 |
Number of pages | 13 |
Journal | Annals of neurology |
Volume | 96 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2024 |
Funding
NIH/NINDS R61NS120249 to Dr. Dennis. Dr. Menon is an Emeritus Senior Investigator of the National Institute for Health Research, UK, and is supported by the CENTER\u2010TBI grant from the European Union and the TBI\u2010REPORTER grant from UKRI, NIHR, AR UK and UK Ministry of Defense. Israel Innovation Authority, \u201CMagneton\u201D Grant to Dr Livny. Maryland Technology Development Corporation1 R01 EY028039 Congressionally Directed Medical Research, JH Discovery Award to Dr. Koliatsos. National Institute for Health and Care Research (NIHR) Advanced Fellowship to Dr. Newcombe. NHMRC Early Career Fellowship to Dr. Spitz. NIH grants R01NS100973, R01AG079957 and RF1AG082201, DoD contract W81XWH\u201018\u20101\u20100413, an anonymous donor family, and the Hanson\u2010Thorell Research Scholarship Fund at the University of Southern California to Dr. Irimia. NIH/NIA R01AG061028, NIH/NINDS RF1NS115268, NIH/NINDS RF1NS128961 and NIH/NINDS/NICHD1U01NS086625\u201001 to Dr. Dams\u2010O'Connor. NIH/NINDS R01\u2010NS121107 to Dr. Dobryakova. PA Health Research Grant SAP #4100077082 to Dr. Hillary. The European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (ERC Starting Grant, Grant agreement No. 802998) and the Research Council of Norway (249795) to Dr. Westlye. To Dr. Caeyenberghs: The Victorian Near\u2010miss Award Pilot is administered by veski for the Victorian Health and Medical Research Workforce Project on behalf of the Victorian Government and the Association of Australian Medical Research Institutes. Funding for the Pilot has been provided by the Victorian Department of Jobs, Precincts and Regions. The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (2020/39645) to Dr. Olsen. Tiny Blue Dot Foundation to Dr. Monti. Transport Accident Commission to Dr. Ponsford. NIH U54EB020403, R01MH116147, R56AG058854, P41EB015922, R01MH111671 to Dr. Thompson. VA R&D SPIRE AWARD. Dr. Olsen is a co\u2010founder and owner of Nordic Brain Tech AS. Dr. Zafonte received royalties from: (1) Oakstone for an educational CD\u2010 Physical Medicine and Rehabilitation a Comprehensive Review; (2) Demos publishing for serving as co\u2010 editor of the text Brain Injury Medicine. Dr Zafonte serves on the Scientific Advisory Board of Myomo, Oxeia Biopharma, Biodirection and ElMINDA. He also evaluates patients in the MGH Brain and Body\u2010TRUST Program which is funded by the NFL Players Association. Dr. Adamson is the CEO & Founder of Soof Solutions Inc. Dr. Cole is a scientific advisor and shareholder of Claritas HealthTech PTE and of BrainKey. Dr. Thompson received partial research support from Biogen, Inc., for research unrelated to this manuscript.
ASJC Scopus subject areas
- Neurology
- Clinical Neurology